A- A+ facebook twitter email print Siponimod Improves Cognition in Advanced Multiple Sclerosis December 17, 2020, 1:42 pm Spionimod, a second-generation MS drug, achieves clinically meaningful improvement in cognitive processing speed for patients with advanced disease. Read More https://www.medscape.com/viewarticle/942807